By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Carl Zeiss Meditec AG (CZMWY) Discusses CEO Transition and Management Continuity Strategy Following Code of Conduct Investigation Transcript
News

Carl Zeiss Meditec AG (CZMWY) Discusses CEO Transition and Management Continuity Strategy Following Code of Conduct Investigation Transcript

News
Last updated: 2025/12/11 at 5:57 PM
By News
Share
2 Min Read
SHARE

Operator

Good morning, ladies and gentlemen, and welcome to the Carl Zeiss Meditec follow-up call regarding the CEO change announcement. [Operator Instructions] Let me now turn the floor over to your host, Sebastian Frericks, Head of Investor Relations.

Sebastian Frericks
Director of Investor Relations

Welcome. Good morning, and thank you for joining this short notice call. I’m Sebastian, I’m the Head of IR at Carl Zeiss Meditec. For our U.S.-based investors and also our U.K. investors whom it is quite early today, a replay and transcript of the call will be made available quickly after we conclude here.

Surely, all of you have read our news yesterday afternoon regarding the CEO change. With today’s call, it is our goal to provide to you an outlook on how we intend to move forward in the short to mid-term with management as well on how we expect to achieve continuity and strategy in the future.

With no further ado, let me hand it over first to our CFO, Justus. In just a moment, we will also have Andreas, CEO of Zeiss Group and our designated Interim CEO as of January 1, make some comments on the situation. Afterwards, both will be available for some questions. Please note that this call will have to be concluded after about 30 to 40 minutes. So I will kindly ask you to keep questions short and

Read the full article here

News December 11, 2025 December 11, 2025
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Wall Street Lunch: Disney Invests $1B In OpenAI, Inks License Deal For Content Generation

By News
News

Gold Royalty Corp. (GROY) Discusses Acquisition of Pedra Branca Royalty and Related Equity Financing Transcript

By News
News

Evertz Technologies Limited (ET:CA) Q2 2026 Earnings Call Transcript

By News
News

Chimera Investment Corporation: We Play Defense With The Bonds (NYSE:CIM)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?